The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), ...

Eli Lilly and Novo Nordisk are the two biggest names in the pharmaceutical sector, but I see one as the clear-cut winner for ...

Savannah Mendoza used to spend most of her paychecks on food delivery apps and at fast food drive-thrus, trying to satisfy a ...

“These findings suggest that BMI and obesity prevalence in the U.S. decreased in 2023 for the first time in more than a ...

Anti-obesity medication use was associated with reduced alcohol consumption among patients in a telehealth medical weight ...

CagriSema is a fixed-dose combination of cagrilintide, a long-acting amylin analogue, and semaglutide, a glucagon-like peptide-1 receptor agonist.

The US Food and Drug Administration approved a generic once-daily injectable version of the glucagon-like peptide-1 receptor ...

FDA Approves First Generic of Once-Daily GLP-1 Injection to Lower Blood Sugar in Patients with Type 2 Diabetes ...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients ...

The US Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea (OSA).

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

The nod, just months after topline results from SURMOUNT-OSA came out, makes it the first drug approved for this indication.